In a retrospective Japanese study28, the proportion of patients with high serum KL-6 levels (> 500 U/mL) was higher among patients with lung cancer with ILD (73.5%) than among those without ILD (33.7%). The gene discussed is MUC1; the disease is lung carcinoma.